-
Clinical and economic benefits of image-guided system in functional endoscopicsinus surgery: a retrospective chart review study in China
Author: Wang, Zaixing; Liu, Chunling; Tan, Baoying; Sun, Guoqing; Pang, Poucheok; Lv, Kangchen; Xie, Hui; Ou, Xiong; Zeng, Xianhai; Xuan, Jianwei
Journal: COST EFFECTIVENESS AND RESOURCE ALLOCATION. 2023; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s12962-023-00414-2
-
Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in Boao Lecheng Pilot Zone
Author: Li, Jiahe; Liu, Lichang; Cao, Haijun; Yang, Mei; Sun, Xin
Journal: COST EFFECTIVENESS AND RESOURCE ALLOCATION. 2023; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s12962-022-00412-w
-
Cost-effectiveness analysis of adding durvalumab to chemotherapy as first-line treatment for advanced biliary tract cancer based on the TOPAZ-1 trial
Author: Zhao, Qiuling; Xie, Ruixiang; Zhong, Wanfu; Liu, Wenbin; Chen, Ting; Qiu, Xiuliang; Yang, Lin
Journal: COST EFFECTIVENESS AND RESOURCE ALLOCATION. 2023; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s12962-023-00429-9
-
Cost-effectiveness analysis of sorafenib, lenvatinib, atezolizumab plus bevacizumab and sintilimab plus bevacizumab for the treatment of advanced hepatocellular carcinoma in China
Author: Gong, Hongyu; Ong, Siew Chin; Li, Fan; Weng, Zhiying; Zhao, Keying; Jiang, Zhengyou
Journal: COST EFFECTIVENESS AND RESOURCE ALLOCATION. 2023; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s12962-023-00435-x
-
Associations between treatment burden, self-reported treatment qualities, antiretroviral therapy obtainment, and health-related quality of life among Ugandan PLWH
Author: Guan, Ming; Guan, Hongyi
Journal: COST EFFECTIVENESS AND RESOURCE ALLOCATION. 2023; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s12962-023-00434-y
